124 related articles for article (PubMed ID: 8609215)
1. Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites.
Pillay TS; Xiao S; Olefsky JM
J Clin Invest; 1996 Feb; 97(3):613-20. PubMed ID: 8609215
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity.
Usui I; Takata Y; Imamura T; Morioka H; Sasaoka T; Sawa T; Ishihara H; Ishiki M; Kobayashi M
Diabetologia; 1997 Aug; 40(8):894-901. PubMed ID: 9267983
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
Valverde AM; Teruel T; Lorenzo M; Benito M
Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
[TBL] [Abstract][Full Text] [Related]
5. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.
Almind K; Inoue G; Pedersen O; Kahn CR
J Clin Invest; 1996 Jun; 97(11):2569-75. PubMed ID: 8647950
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the mitogen-activated protein kinase/90-kilodalton ribosomal protein S6 kinase signaling pathway in 3T3-L1 adipocytes and its role in insulin-stimulated glucose transport.
Fingar DC; Birnbaum MJ
Endocrinology; 1994 Feb; 134(2):728-35. PubMed ID: 8299568
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts.
Xu XQ; McGuire TF; Blaskovich MA; Sebti SM; Romero G
Arch Biochem Biophys; 1996 Feb; 326(2):233-7. PubMed ID: 8611028
[TBL] [Abstract][Full Text] [Related]
8. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
[TBL] [Abstract][Full Text] [Related]
9. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
10. Effect of phosphotyrosyl-IRS-1 level and insulin receptor tyrosine kinase activity on insulin-stimulated phosphatidylinositol 3, MAP, and S6 kinase activities.
Wilden PA; Broadway DE
J Cell Physiol; 1995 Apr; 163(1):9-18. PubMed ID: 7896903
[TBL] [Abstract][Full Text] [Related]
11. The level of insulin receptor tyrosine kinase activity modulates the activities of phosphatidylinositol 3-kinase, microtubule-associated protein, and S6 kinases.
Wilden PA; Kahn CR
Mol Endocrinol; 1994 May; 8(5):558-67. PubMed ID: 8058065
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action.
Mothe I; Van Obberghen E
J Biol Chem; 1996 May; 271(19):11222-7. PubMed ID: 8626671
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.
De Fea K; Roth RA
Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for the insulinomimetic effects of C-peptide.
Grunberger G; Qiang X; Li Z; Mathews ST; Sbrissa D; Shisheva A; Sima AA
Diabetologia; 2001 Oct; 44(10):1247-57. PubMed ID: 11692173
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling.
Fiory F; Alberobello AT; Miele C; Oriente F; Esposito I; Corbo V; Ruvo M; Tizzano B; Rasmussen TE; Gammeltoft S; Formisano P; Beguinot F
Mol Cell Biol; 2005 Dec; 25(24):10803-14. PubMed ID: 16314505
[TBL] [Abstract][Full Text] [Related]
17. Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1.
Chin JE; Liu F; Roth RA
Mol Endocrinol; 1994 Jan; 8(1):51-8. PubMed ID: 7512195
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
19. Mutation of the two carboxyl-terminal tyrosines in the insulin receptor results in enhanced activation of mitogen-activated protein kinase.
Pang L; Milarski KL; Ohmichi M; Takata Y; Olefsky JM; Saltiel AR
J Biol Chem; 1994 Apr; 269(14):10604-8. PubMed ID: 8144649
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
